3D Global Biotech Inc. (TPEX:6808)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
57.70
+4.50 (8.46%)
May 14, 2025, 1:56 PM CST
78.64%
Market Cap 4.14B
Revenue (ttm) 265.69M
Net Income (ttm) 91.70M
Shares Out 77.84M
EPS (ttm) 1.30
PE Ratio 40.92
Forward PE n/a
Dividend 0.53 (1.02%)
Ex-Dividend Date n/a
Volume 1,092,306
Average Volume 190,569
Open 53.20
Previous Close 53.20
Day's Range 53.20 - 59.40
52-Week Range 31.20 - 73.50
Beta 0.37
RSI 51.12
Earnings Date Apr 25, 2025

About 3D Global Biotech

3D Global Biotech Inc. develops medical materials for human body reconstruction in China. It uses cell culture systems, 3D printing technology, and bio-inks hydrogel as the basis to develop and produce customized autologous cell-based medical products. The company develops human tissue and organ reconstruction platforms; develops customized and personalized medical equipment; and conducts professional research. It offers artificial bone substitute, skull fixation system, biological dressings, bio inks, and bioprinting equipment, as well as orth... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 43
Stock Exchange Taipei Exchange
Ticker Symbol 6808
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.